Shandong Financial Statements From 2010 to 2025

Stocks . China . 
Stock . Shandong Pharmaceutical Glass
600529 Stock   25.01  0.25  0.99%   
Shandong Pharmaceutical financial statements provide useful quarterly and yearly information to potential Shandong Pharmaceutical Glass investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Shandong Pharmaceutical financial statements helps investors assess Shandong Pharmaceutical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Shandong Pharmaceutical's valuation are summarized below:
Gross Profit
1.1 B
Profit Margin
0.1718
Market Capitalization
16.6 B
Enterprise Value Revenue
2.7085
Revenue
5.1 B
We have found seventy-four available fundamental trend indicators for Shandong Pharmaceutical Glass, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Shandong Pharmaceutical Glass current market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road.

Shandong Pharmaceutical Total Revenue

6.02 Billion

Check Shandong Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shandong Pharmaceutical's main balance sheet or income statement drivers, such as Interest Expense of 512.3 K, Selling General Administrative of 177.4 M or Total Revenue of 6 B, as well as many indicators such as . Shandong financial statements analysis is a perfect complement when working with Shandong Pharmaceutical Valuation or Volatility modules.
  
This module can also supplement various Shandong Pharmaceutical Technical models . Check out the analysis of Shandong Pharmaceutical Correlation against competitors.

Shandong Pharmaceutical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets11.3 B10.7 B5.2 B
Slightly volatile
Other Current Liabilities131.4 M80.4 M128.5 M
Slightly volatile
Total Current Liabilities2.1 B2 B1.1 B
Slightly volatile
Total Stockholder Equity9.1 B8.7 B4.1 B
Slightly volatile
Retained Earnings4.3 B4.1 B2.1 B
Slightly volatile
Accounts Payable1.7 B1.6 B894.7 M
Slightly volatile
Cash1.8 B1.7 B813 M
Slightly volatile
Long Term Debt28 M22.5 M26.5 M
Slightly volatile
Net Receivables622.7 M1.1 B710.8 M
Slightly volatile
Inventory1.3 B1.2 B694.1 M
Slightly volatile
Other Current Assets76.8 M40.3 M56.3 M
Slightly volatile
Total Liabilities2.2 B2.1 B1.2 B
Slightly volatile
Intangible Assets306.3 M291.7 M139.4 M
Slightly volatile
Common Stock801.3 M763.2 M440.4 M
Slightly volatile
Property Plant Equipment3.4 B3.2 B1.8 B
Slightly volatile
Other Assets461.2 M439.2 M172.8 M
Slightly volatile
Other Liabilities71.2 M67.8 M39.1 M
Slightly volatile
Short Term Investments1.5 B1.4 B519.1 M
Slightly volatile
Net Tangible Assets4.2 B7.7 B3.7 B
Slightly volatile
Other Stockholder Equity59.8 M86.8 M51.7 M
Slightly volatile
Long Term Investments40 K45 K49.1 K
Slightly volatile
Total Current Assets3.7 B6.4 B3 B
Slightly volatile
Non Current Assets Total2.7 B4.3 B2.2 B
Slightly volatile
Non Currrent Assets Other18.3 M19.3 M66.7 M
Slightly volatile
Non Current Liabilities Total51.7 M66.3 M41.1 M
Slightly volatile
Short and Long Term Debt2.9 M2.1 M2.8 M
Slightly volatile
Short Term Debt800 K900 K981.2 K
Slightly volatile
Common Stock Shares Outstanding676 M763.2 M619.1 M
Slightly volatile
Net Invested Capital5.4 B8.7 B4.4 B
Slightly volatile
Net Working Capital2.6 B4.4 B2.3 B
Slightly volatile
Capital Stock648.5 M763.2 M521.8 M
Slightly volatile
Property Plant And Equipment Net2.8 B4 B2.3 B
Slightly volatile
Property Plant And Equipment Gross3.9 B5.9 B3.4 B
Slightly volatile

Shandong Pharmaceutical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative177.4 M210.3 M190.4 M
Very volatile
Total Revenue6 B5.7 B2.9 B
Slightly volatile
Operating Income1.1 B1 B484.6 M
Slightly volatile
Cost Of Revenue4.3 B4.1 B2 B
Slightly volatile
Income Before Tax1.1 B1 B470.7 M
Slightly volatile
Net Income Applicable To Common Shares746.6 M711 M362.1 M
Slightly volatile
Net Income936.8 M892.2 M395.2 M
Slightly volatile
Income Tax Expense52.4 M103.2 M62.6 M
Slightly volatile
Minority Interest10.3 M9.8 M8.2 M
Slightly volatile
Research Development103.4 M158.6 M75.8 M
Slightly volatile
Gross Profit1.1 B1.6 B877.8 M
Slightly volatile
Other Operating Expenses24.2 M20.7 M27.7 M
Pretty Stable
Net Income From Continuing Ops484.4 M892.2 M378.9 M
Slightly volatile
EBIT532.3 M813.3 M435.1 M
Slightly volatile
Total Operating Expenses2.8 B4.7 B2.4 B
Slightly volatile
Tax Provision91.6 M155.3 M75.9 M
Slightly volatile
Net Interest Income27.4 M26.1 M8.7 M
Slightly volatile
Interest Income31 M29.6 M10.2 M
Slightly volatile
EBITDA831.8 M1.2 B668.9 M
Slightly volatile
Reconciled Depreciation242.1 M373.9 M198.5 M
Slightly volatile

Shandong Pharmaceutical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Income936.8 M892.2 M395.2 M
Slightly volatile
Dividends Paid240.4 M228.9 M111.9 M
Slightly volatile
Total Cash From Operating Activities1.3 B1.2 B520.5 M
Slightly volatile
Other Cashflows From Investing Activities7.8 M8.2 M11.6 M
Pretty Stable
Depreciation221.7 M373.9 M193.8 M
Slightly volatile
Change To Operating Activities6.5 M10.6 M6.4 M
Slightly volatile
Change To Netincome46.8 M32.2 M39.3 M
Very volatile
End Period Cash Flow1.1 B1.5 B1.1 B
Very volatile
Begin Period Cash Flow751.2 M1 B1 B
Slightly volatile

About Shandong Pharmaceutical Financial Statements

Shandong Pharmaceutical stakeholders use historical fundamental indicators, such as Shandong Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Shandong Pharmaceutical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Shandong Pharmaceutical's assets and liabilities are reflected in the revenues and expenses on Shandong Pharmaceutical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Shandong Pharmaceutical Glass. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue5.7 B6 B
Cost Of Revenue4.1 B4.3 B

Currently Active Assets on Macroaxis

BTCBitcoin
TRXTRON
BNBBinance Coin
ADACardano
XRPXRP

Other Information on Investing in Shandong Stock

Shandong Pharmaceutical financial ratios help investors to determine whether Shandong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shandong with respect to the benefits of owning Shandong Pharmaceutical security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY